Safety Reference
Warning
H373May cause damage to organs through prolonged or repeated exposure
H412Harmful to aquatic life with long lasting effects
Sourcing Relebactam?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Clavulanate potassium
pharmaceutical raw material
Sourcing Relebactam?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Relebactam is a diazabicyclooctane beta-lactamase inhibitor, structurally similar to avibactam, and serves as an active pharmaceutical ingredient used in combination with imipenem and cilastatin. It features a piperidine ring that imparts a positive charge, reducing bacterial export, and was approved by the FDA in 2019 as part of the Recarbrio® combination product for treating complicated urinary tract infections, pyelonephritis, and complicated intra-abdominal infections in adults.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Relebactam (CAS 1174018-99-5) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
SMOBCLHAZXOKDQ-ZJUUUORDSA-N
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3